Vera Therapeutics, Inc.
VERA
$36.70
$0.090.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.86% | -13.46% | -4.92% | -48.05% | -19.04% |
| Total Depreciation and Amortization | 3.70% | 4.65% | 8.40% | 40.00% | 54.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 165.13% | 10.80% | 16.28% | 23.96% | 35.09% |
| Change in Net Operating Assets | -232.48% | 19.30% | -35.09% | 241.79% | -1,196.43% |
| Cash from Operations | -52.16% | -13.06% | -12.97% | -0.72% | -38.85% |
| Capital Expenditure | 77.45% | 23.31% | 36.06% | -11.23% | 71.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -270.61% | 15.55% | 143.09% | 85.45% | 107.02% |
| Cash from Investing | -270.85% | 15.63% | 144.40% | 86.36% | 106.92% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.70% | 38,066.50% | 71.77% | -69.73% | -99.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -98.62% | 35,819.95% | -96.07% | 1,223.22% | -99.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.95% | 3,332.18% | 244.95% | 84.11% | -157.43% |